Posted in | News

Freeman Technology is pleased to announce the release of ‘Capsule Filling’.

In the pharmaceutical industry, the blending of a small fraction of active pharmaceutical ingredient (API) with a bulk excipient, and the subsequent processing through various unit operations, is an essential part of many manufacturing processes. The way that the blend behaves in downstream processes will be a function of the properties of the components of that blend.

Formulations delivered in capsule form require suitable characteristics to ensure a precise and accurate fill of the dosing capsule. This application note presents a study using the FT4 Powder Rheometer™ to evaluate three powdered formulations used in the production of a Dry Powder Inhaler product. Properties that were conducive to good performance in a dosator were quantified, enabling formulations that will result in high quality final products to be specified.

Please click here to view or download the application note.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Freeman Technology. (2018, March 28). Freeman Technology is pleased to announce the release of ‘Capsule Filling’. . AZoM. Retrieved on April 23, 2024 from https://www.azom.com/news.aspx?newsID=48942.

  • MLA

    Freeman Technology. "Freeman Technology is pleased to announce the release of ‘Capsule Filling’. ". AZoM. 23 April 2024. <https://www.azom.com/news.aspx?newsID=48942>.

  • Chicago

    Freeman Technology. "Freeman Technology is pleased to announce the release of ‘Capsule Filling’. ". AZoM. https://www.azom.com/news.aspx?newsID=48942. (accessed April 23, 2024).

  • Harvard

    Freeman Technology. 2018. Freeman Technology is pleased to announce the release of ‘Capsule Filling’. . AZoM, viewed 23 April 2024, https://www.azom.com/news.aspx?newsID=48942.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.